SIC
EBS icon

SJS Investment Consulting’s Emergent Biosolutions EBS Stock Holding History

SJS Investment Consulting’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31K Buy
156
+104
+200% +$870 ﹤0.01% 1935
2026
Q1 		$432 Buy
52
+36
+225% +$373 ﹤0.01% 1788
2025
Q4 		$198 Buy
+16
New +$171 ﹤0.01% 1812
2023
Q2 		– Sell
-9
Closed -$94 – 1608
2023
Q1 		$94 Hold
9
– – ﹤0.01% 1466
2022
Q4 		$106 Sell
9
-10
-53% -$155 ﹤0.01% 1487
2022
Q3 		$0 Buy
+19
New +$529 ﹤0.01% 1168
2022
Q1 		$0 Buy
+2
New +$88 ﹤0.01% 861

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

SJS Investment Consulting's EBS Position: Q2 2026 in Review

SJS Investment Consulting increased its Emergent Biosolutions (EBS) stake by 200% in Q2 2026, buying an estimated $870 and bringing the position to 156 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

SJS Investment Consulting first reported a position in EBS in Q1 2022 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • SJS Investment Consulting held 156 shares of Emergent Biosolutions worth $1.31K as of Q2 2026.
  • SJS Investment Consulting bought 104 Emergent Biosolutions shares in Q2 2026, an estimated $870.
  • Emergent Biosolutions made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1935 holding.
  • SJS Investment Consulting first reported a position in Emergent Biosolutions in Q1 2022 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.